Market Research Blog – Page 9412 – New Product Development

Biologic Excipients Market Insights on Trends and Growth Forecast by 2032 | FMI

Future Market Insights (FMI) delivers key insights on the Global Biologic Excipients Market in its upcoming report titled “Biologic Excipients Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018 – 2028”. In terms of revenue, the global biologic excipients market is projected to register a CAGR of 3.6% over the forecast period owing to various factors, regarding which FMI offers detailed insights and forecasts in this report.

Request a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-6982

Global Biologic Excipients Market: Segmental Analysis & Forecast

The global market is segmented based on excipient type, end user and region. Based on excipient type the market is segmented into polymers, sugar alcohols, polysorbates, inorganic salts, amino acids, surfactants and others. Polymers biologic excipients are anticipated to lead the biologic excipients market over the forecast period. Polymer biologic excipients account for the highest revenue share and are anticipated to witness a growth rate of 3.7% over the forecast period.

By end user, the market is segmented into biopharmaceutical manufacturers, contract research organisations/contract manufacturing organisations, and research organisations. Biopharmaceutical manufacturers is the leading segment in the global biologic excipients market over the forecast period. This segment accounts for a relatively higher revenue share, which is expected to register a CAGR of 6.0% over the forecast period.

Global Biologic Excipients Market: Dynamics

Growth of the global biologic excipients market is primarily driven by rising global demand for medicines, greater uptake of biologics driving demand for parenteral formulations, increasing acquisition of contract research organisations, patent expiration of major blockbuster drugs, growing adoption of advanced drug delivery technologies, increasing research in pediatric formulations, growing demand for extended-release or sustained release formulations, increasing demand for oral solid drug formulations, rising demand from emerging economies pushing local drug production, and increasing per capita healthcare expenditure.

However, lack of proper data documentation on gras status of excipients, regulatory audits restricting supply capacity, regulatory hurdles detering novel excipient development, and stability testing of excipients imposing cost liabilities on drug manufacturers are some factors expected to hamper the growth of the global biologic excipients market over the forecast period.

Our advisory services are aimed at helping you with specific, customised insights that are relevant to your specific challenges. Let us know about your challenges and our trusted advisors will connect with you: https://www.futuremarketinsights.com/ask-question/rep-gb-6982

A key trend witnessed in the biologic excipients market is increasing adoption of continuous processing of biologic excipients, dependence of large drug manufacturers on in-house biologic excipients production, vast proportion of imported excipients leading to production delays, and regulatory harmonisation with respect to gradation of excipients. Furthermore, the growing importance of developing biologic excipients by big players in order to enhance their product portfolio, growing importance for manufacturing authorisation, growing market for topical and parenteral applications and compulsory licensing promoting demand for biologic excipients are the key trends likely to be witnessed in the global biologic excipients market.

Global Biologic Excipients Market: Regional Analysis

The North America regional market is projected to dominate the global biologic excipients market, accounting for a maximum revenue share of the global market by 2017 end. The North America, Western Europe, and Asia Pacific markets accounted for 77.3% of the total biologic excipients market share in terms of value in 2017. Revenue from the market in APEJ is estimated to expand at a CAGR of 4.2% over the forecast period.

Some of the key players featured in this report on the global biologic excipients market include BASF Corporation, FMC Corporation, Wacker Chemie AG, Evonik Industries AG, Ashland Global Holdings Inc., Archer-Daniels-Midland Co., Roquette Freres S.A., The Dow Chemical Company, Colorcon Inc., Signet Chemical Co. Pvt. Ltd. This report discusses the individual strategies followed by these companies regarding bringing improvements in their products, creating new manufacturing facilities, market consolidation and advanced R&D initiatives. The report concludes with key takeaways for players already present in the market and new players planning to enter the market.

Buy Now@ https://www.futuremarketinsights.com/checkout/6982

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Veterinary Molecular Diagnostics Market Insights, Facts, historical data and Statistics 2022-2032

The global Veterinary Molecular Diagnostics market size is expected to be valued at US$ 182.1 Million in 2022. With the adoption of multiple testing panels, coupled with the growing consolidation in the veterinary diagnostics industry, the overall demand for Veterinary Molecular Diagnostics is projected to grow at a CAGR of 6.84% between 2022 and 2032, totaling around US$ 352.8 Million by 2032.

Request Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-6742

Factors such as the growing pet animal population around the globe, increased animal health spending and advancements in veterinary molecular diagnostics are expected to propel the growth of the veterinary molecular diagnostics market over the analysis period.

Developments in the animal farming sector and changing societal attitude toward pet animals have resulted in an increased demand for fast and reliable diagnostic techniques. Molecular diagnostics possess the potential to address this growing demand.

As of 2018, more than 60% of the US population owned a pet/companion animal. There is an increasing trend of treating pets as family members, which has increased the healthcare demands for veterinary applications. The increasing pet population is one of the reasons for the rising health expenditure on animals, globally.

As per the estimates of the American Pet Products Association, the total American pet industry expenditure is expected to reach USD 75.38 billion by end 2019, up from USD 72.56 billion in 2018. The rise in animal health expenditure is expected to drive the growth of the veterinary molecular diagnostics market, as a significant portion of pet owners are expected to use advanced diagnostic modalities for animals, for various disease conditions.

Furthermore, there is an increase in the livestock population, owing to the huge demand for animal-derived products. This is expected to increase the demand for molecular diagnostic tests in the next coming years.

The Veterinary Molecular Diagnostics Market in the US is expected to accumulate the highest market share of 34.6% in 2022. The United States is expected to dominate the market, attributed to factors, such as rising pet adoption and increasing per capita animal healthcare expenditure. In addition, the rise in the prevalence of various animal diseases and injuries is another major factor that is anticipated to fuel the market growth during the forecast period.

The high growth in the number of veterinary practitioners and rise in income levels in developed economies is amongst the important factors intensifying the growth and demand of veterinary molecular diagnostics market. In addition, the increasing demand for pet insurance and growing animal health expenditure is also contributing to the growth in the global market during the forecast period.

Talk to Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-6742

In addition, the increasing demand for animal-derived food products and rising incidence of animal zoonotic diseases are also enhancing the growth of the market. Likewise, the high growth in companion animal population is also lifting the market growth in the forthcoming years.

Key Takeaways from the Market Study

Global Veterinary Molecular Diagnostics Market was valued at US$ 182.1 Mn by 2022-end
From 2017 to 2021, the market demand expanded at a CAGR of 7.3%
By Product Type, the PCR Kits segment of the Veterinary Molecular Diagnostics Market constitutes the bulk of the market with a market share of 50.8%
By Species Type, the Livestock Animals segment dominates the market with a share of 71.0%
From 2022 to 2032, Veterinary Molecular Diagnostics sales are expected to flourish at a CAGR of 6.84%.
By 2032, the market value of Veterinary Molecular Diagnostics is expected to reach US$ 352.8 Mn.

“Factors such as the rising per capita animal healthcare expenditure, coupled with rising pet adoption globally are expected to escalate the growth of the Veterinary Molecular Diagnostics Market over the analysis period”, remarks an FMI analyst.

Competitive Landscape

Players in the global Veterinary Molecular Diagnostics Market focus on expanding their global reach through various strategies, such as; partnerships, collaborations, and partnerships. The players are also making a significant investment in R&D to add innovations to their products which would help them in strengthening their position in the global market. Some of the recent developments among the key players are:

In April 2021, INDICAL BIOSCIENCE GmbH (Germany) acquired Boehringer Ingelheim’s Svanova product portfolio which helped INDICAL widen its portfolio by adding 25 assays for livestock.
In April 2021, BioChek (Netherlands) opened a new office in Johannesburg, South Africa.
In January 2021, Heska Corporation (US) acquired Lacuna Diagnostics (US), this acquisition strengthened the company’s portfolio of point-of-care digital cytology technology and telemedicine services.
In December 2020, NEOGEN Corporation (US) launched a preventative care DNA screening tool for detecting genetic diseases in dogs.
In November 2020, NEOGEN Corporation (US) collaborated with Transnetyx Inc. (US), this partnership helped NEOGEN to increase its presence in the animal genomics and diagnostics market.

Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-6742

Key Players:

bioMérieux SA
IDEXX Laboratories, Inc.
Neogen Europe, Ltd.
Veterinary Molecular Diagnostics, Inc.
Thermo Fisher Scientific, Inc.
ID-Vet, Qiagen N.V.

Key Segments Covered in the Veterinary Molecular Diagnostics Industry Analysis

Veterinary Molecular Diagnostics Market by Product Type:

Veterinary Molecular Diagnostics PCR Kits
Veterinary Molecular Diagnostics INAAT Kits
Veterinary Molecular Diagnostics Microarray Kits
Veterinary Molecular Diagnostics DNA Sequencing Kits

Veterinary Molecular Diagnostics Market by Species Type:

Veterinary Molecular Diagnostics for Livestock Animals
Veterinary Molecular Diagnostics for Companion Animals

Veterinary Molecular Diagnostics Market by Disease Type:

Veterinary Molecular Diagnostics for Anaplasma spp.
Veterinary Molecular Diagnostics for Ehrlichia spp.
Veterinary Molecular Diagnostics for New Castle Disease
Veterinary Molecular Diagnostics for Influenza
Veterinary Molecular Diagnostics for Porcine Reproductive & Respiratory Syndrome (PRRS)
Others

Veterinary Molecular Diagnostics Market by End-User:

Veterinary Molecular Diagnostics for Veterinary Hospitals
Veterinary Molecular Diagnostics for Clinical Laboratories
Veterinary Molecular Diagnostics for Veterinary Research Institutes

About Future Market Insights (FMI)

Contact:

Peripheral Embolization Device Market Segment Overview, Regional Analysis and Forecast 2022-2026

Embolization is a process through which embolus is placed into the blood vessel to block the blood flow to a particular area of the body. The embolus is usually a blood clot formed due to clotting of blood cells. However, the artificial embolus is used to close off blood vessels to prevent the blood from reaching a particular part of the body to eliminate abnormal conditions in the body like a renal aneurysm, arteriovenous fistula, hypogastric artery embolization, endoleak embolization, GI bleeding and treatment of tumors. Peripheral embolization is usually used to shrink tumors by blocking the blood flow to it. Peripheral embolization devices often use embolus made up of various drugs which along with blocking the blood flow also are targeted towards the treatment of a tumor. Embolization is efficient and less invasive as compared to open surgery and therefore poses a little risk to the patient.

Request a Sample of this Report @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1793

Peripheral Embolization Device Market: Drivers and Restraints

The global peripheral embolization device market is driven by the rising incidence of cancer and cardiovascular diseases. According to CDC (Centers for Disease Control and Prevention) by 2025, 19.3 million cases of cancer cases are expected to be diagnosed each year, which in turn is expected to increase demand for peripheral embolization devices for early treatment of malignant tumors. The increasing mortality rate due to cardiovascular diseases is expected to boost demand for peripheral embolization devices. Increasing cardiovascular patients owing rising global geriatric population is expected to provide high growth opportunities for the peripheral embolization devices manufacturers over the forecast period. Moreover, technological developments in new peripheral embolization devices aimed to increase safety among patients and ease of use for physicians is expected to provide significant growth opportunities for the peripheral embolization devices manufacturers. However, the high cost of peripheral embolization devices and complications like coil migration, perforations, and spasms among patients is expected to hamper market growth over the forecast period.

Peripheral Embolization Device Market: Region – wise Outlook

The peripheral embolization device market is expected to witness healthy growth throughout the forecast period with North America expected to be the leading market. High demand for peripheral embolization devices from cancer patients is expected to boost the market growth over the forecast period. Favorable reimbursement policies and up gradation in the compensation for the patients is North America is projected to drive demand for peripheral embolization devices in North America over the forecast period. Moreover, several global manufacturers in this region are expected to promote the use of peripheral embolization devices and in turn is supposed to increase the adoption rate of the devices. Western Europe is expected to be second largest market followed by North America owing to high awareness related to the use of peripheral embolization devices for treatment of cardiovascular and bleeding disorders. APEJ (Asia-Pacific excluding Japan) and Japan are expected to follow next after Western Europe owing to high population and increasing the incidence of cardiovascular diseases in these regions along with growing per capita healthcare expenditure in countries like India and China. Eastern Europe and the Middle East and Africa (MEA) is expected to increase significantly owing to the rise in cancer incidence rate and manufacturers focusing on expansion strategies in this regions.

Peripheral Embolization Device Market: Key Players

Some key players in peripheral embolization market are Boston Scientific Corporation, Medtronic, Inc., Cook Medical, St. Jude Medical, Inc., Penumbra, Inc., Metactive Medical, Inc., Terumo Corporation and others. The companies are focused on development of new peripheral embolization devices with increased safety and ease of use.

Ask An Analyst @ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-1793

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Current Trends/Issues/Challenges
Competition & Companies involved
Value Chain

Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico. Brazil)
Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg)
Eastern Europe (Poland, Russia)
APEJ (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC, S. Africa, N. Africa)

Peripheral Embolization Device Market: Segmentation

The global peripheral embolization device market are segmented into product type and end user

Segmentation based on product type

Embolization Guidewires
Microcatheters
Occlusion Systems
Occlusion Balloons
Platinum Coils

Segmentation based on end user

Hospitals
Ambulatory surgical centers
Specialty clinics

Buy Complete Report @ https://www.futuremarketinsights.com/checkout/1793

Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint

About Future Market Insights (FMI)

Contact:

Personalized Medicine Market Positioning and Growing Market Share Worldwide | FMI

With 1000+ market research reports and 1 billion+ data points, Future Market Insights (FMI) serves each and every requirement of the clients operating in the global healthcare, pharmaceuticals, and medical device industries. FMI deploys digital intelligence solutions to offer compelling insights to report buyers that help them in overcoming market challenges, especially at the time of a crisis. Our dedicated team of professionals performs an extensive survey for gathering accurate information associated with the market.

Request Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-1511

FMI, in its upcoming business report, elaborates the historical and current scenario of the global Personalized Medicine market in terms of production, consumption, volume, and value. The report scrutinizes the market into various segments, regions and players on the basis of demand pattern and growth prospects.

Crucial information and forecast statistics covered in the Personalized Medicine market report will arm both existing and emerging market players with necessary insights to craft long-term strategies as well as maintain business continuity during a crisis such as the ongoing COVID-19 pandemic.

COVID-19 Impact Analysis on Personalized Medicine Market

The recent outbreak of the COVID-19 has turned the spotlight on the healthcare industry, and subsequently impacted the Personalized Medicine market. Severe shortages of critical medical supplies and a rapid rise in number of COVID-19 cases have resulted into a revolution rather than evolution in the healthcare ecosystems. Consequently, the impact is noticeable in the Personalized Medicine market.

Following government’s measures, particularly social distancing norms and stay-at-home orders, doctors are delaying or postponing elective surgeries unless critical to prevent the spread of the virus to individuals with comorbidities or chronic conditions. Additionally, movement restrictions and supply chain disruptions have created a logistical nightmare for market players, leading to severe product shortages in the global marketplace.

The FMI’s report includes an interesting chapter on preliminary impact of the COVID-19 on the Personalized Medicine market. This allows both leading and emerging market players to understand the market scenario during a crisis and aids them in making sound decisions to gain a distinct competitive edge.

Why Choose Future Market Insights

Serving domestic and international clients 24/7
Prompt and efficient customer service
Data collected from reliable primary and secondary sources
Highly trained and experienced team of research analysts
Seamless delivery of tailor-made market research reports

Discounted prices for new customers! Offer expires soon!

Ask an Analyst@ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-1511

Personalized Medicine Market: Segmentation

Valuable information covered in the FMI’s Personalized Medicine market report has been segregated into key segments and sub-segments.

Segmentation based on Therapeutic area

Oncology
Neurology
Cardiology
Antiviral
Psychiatry
Others

Segmentation based on End User

Hospitals
Molecular Diagnostic Laboratories and Testing facilities
Academic Institutes, clinical care and Research Laboratories
Contract Research Organizations
Bio and health informatics companies
Others (Service providers, partners, venture capitalists, etc.)

Segmentation based on Application

Companion Diagnostics
Biomarker identification
Health Informatics
Clinical Research

Personalized Medicine Market: Competition Analysis

The FMI’s study presents a comprehensive analysis of global, regional, and country-level players active in the Personalized Medicine market. Competitive information detailed in the Personalized Medicine market report has been based on innovative product launches, distribution channels, local networks, industrial penetration, production methods, and revenue generation of each market player. Furthermore, growth strategies and mergers & acquisitions (M&A) activities associated with the players are enclosed in the Personalized Medicine market report.

Key players covered in the report include:

Roche Holding AG, Astra Zeneca PLC, Vertex Pharmaceuticals Inc., Qiagen Inc., BD (Becton Dickinson & Co., Merck & Co. Inc., Pfizer Inc., American Association for Cancer Research, Siemens Healthcare Diagnostics, Inc. among others.

Important Questions Answered in the Personalized Medicine Market Report

Which end user remains the top revenue contributor in different regional markets?
At what rate has the global Personalized Medicine market been expanding during the forecast period?
How will the global Personalized Medicine market look like by the end of the forecast period?
What innovative strategies are adopted by Personalized Medicine market players to stay ahead of the pack?
What are the restraints affecting the growth of the global Personalized Medicine market?

Buy Now Complete Report@ https://www.futuremarketinsights.com/checkout/1511

Key Offerings of the Report

Growth Drivers and Opportunities: Comprehensive analysis on growth-driving factors and opportunities for market players in different regional markets
Recent Trends and Forecasts: Detailed assessment on the latest trends, technological developments, and forecasts for a 5-year or 10-year period.
Segmental Analysis: Extensive analysis on each segment and factors differentiating the role of these segments in market revenue forecasts and growth rate analysis
Regional Market Forecast: Thorough analysis of each regional market to arm stakeholders with necessary information to take critical decisions
Competitive Landscape: All-inclusive insights on both leading and emerging players vying for a slice of the Personalized Medicine market

About Future Market Insights (FMI)

Contact:

Kids Sports Injury Treatment Market: Innovative and Technological Advancement

The number of kids taking part in sports activities has been increasing rapidly over the last few years which is resulting in a significant rise in the sport injury incidences. Even though there are various advanatges of active participation in sports, such as physical fitness, building up of self-confidence and learning to work in a team, there is always a risk of sports-related injuries.

Request Sample PDF: https://www.futuremarketinsights.com/reports/sample/rep-gb-1214

The associated risk of an injury increases by a lack of protective gear during sports activities like hockey, boxing, wrestling, skateboarding, Ice hockey, soccer, snow skiing or snowboarding, bicycling, baseball, softball, basketball. Kids sports injuries are injuries which may either develop as a result of inappropriate practice or training. Head injury, elbow injury and soft-tissue injuries are the most common sport injuries in kids.

According to the United State Centers for Disease Control and Prevention, more than 38 Mn adults and children in the U.S. participate in organized sports competitions every year and approximately 2.6 Mn will be treated for injuries related to sports.

Kids Sports Injury Treatment Market: Drivers and Restraints

The primary factor for the growth of global kids’ sports injury market is growing accidents during practice or during performance as the number of children participants in sport activities increases every year from all the age groups. Adequate sports training programs are conducted through private trainers and sport clubs to reduce the accident rate while training so that associated risks are minimized during performances or competitions.

Main factor that restrain the global kids sports injury treatment market is increasing awareness of the parents, providing modified training programs and using safety tools, equipment or safety apparels for the children while practicing.

Kids Sports Injury Treatment Market: Overview

According to the data from the United State Consumer Product Safety Commission’s National Electronic Injury Surveillance System of 100 hospital emergency departments, most of patients that are injured between the age of five and 16 years are injures while playing or practicing basketball, football, baseball, ice hockey, soccer or softball. A kid should get first-aid attention immediately for acute injuries. A visit to a pediatrician is essential even if the injury appears normal and proper diagnosis is necessary for quick healing.

Inquire Before Buying Research Report: https://www.futuremarketinsights.com/ask-question/rep-gb-1214

Kids Sports Injury Treatment Market: Region-wise Outlook

The global kids’ sports injury treatmentmarket is expected to register a healthy CAGR during the forecast period. Depending on geographic region, global kids’ sports injury treatment market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa.

North America held largest share in the global market of kids’ sports injury treatment market followed by Europe, Japan and APAC owing to increase in the number of accidents while playing and developed healthcare infrastructure. The developing nations in APAC, MEA hold huge potential for growth in the global kids’ sports injury treatment market, due to the awareness and concern in the parents in regards to their children.

Kids Sports Injury Treatment Market: Key Players

Some of the key participating global players in kids’ sports injury treatment markets are Stop Sports Injuries, Arthrex, Inc., Smith and Nephew plc. Stryker Corporation, Zimmer Biomet Holdings Inc.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

Buy Now@ https://www.futuremarketinsights.com/checkout/1214

Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico, Brazil, Rest of Latin America)
Western Europe (Germany, Italy, U.K, Spain, France, Rest of Western Europe)
Eastern Europe (Poland, Russia)
Asia Pacific (China, India, ASEAN, Australia & New Zealand)
Japan
Middle East and Africa (GCC, S. Africa, N. Africa)

The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

About Future Market Insights (FMI)

Contact:

Global Medication Management System Market Detail Analysis of Current and Future Projection 2022-2032

In 2022, it is anticipated that the market for Medication Management Systems will be worth US$2.5 billion. The global market for medication management systems is anticipated to grow at a CAGR of 11% between 2022 and 2032, reaching US$ 7.1 billion. The market is expanding as a result of hospitals investing more money to improve workflow and the quick advancement of medical technology.

To remain ahead of your competitors, request for a sample@
https://www.futuremarketinsights.com/reports/sample/rep-gb-1419

Data Points	Key Statistics
Expected Market Value (2022)	US$ 2.5 Billion
Anticipated Forecast Value (2032)	US$ 7.1 Billion
Projected Growth Rate (2022-2032)	11%

The demand for effective management systems to ensure workflow is driving growth in the global market for medication management systems due to a shortage of pharmacists and healthcare professionals. Due to altered demand-supply patterns brought about by the pandemic, the medical and healthcare industries have undergone significant changes. However, the need to reduce medical errors has grown stronger, driving up demand for medication management systems.

The most recent revision of Future Market Insights’ (FMI) report on the “medication management system” market study provides in-depth analyses of the global industry, growth & restraining factors, and demand-supply trajectories across 20+ countries from 2021 to 2031. The report claims that industry participants will prosper from the increase in machines and inventory management equipment in the healthcare and hospital sectors while focusing on key geographical areas like North America, Europe, and Asia Pacific, to name a few.

Key Takeaways from Market Study

The global medication management system industry to ascend at over 15% CAGR through 2031
High requirement for computerized physician order entry and inventory management solutions is likely to be witnessed
Growing requirement from hospitals and pharmacies to favor manufacturers
On-premise and web-based solutions to gain traction in terms of mode of delivery
The United States to remain the epicenter of the world’s largest medication management system industry North America
Germany to remain dominant in the Europe medication management system industry
Asia-Pacific to exhibit the fastest growth during the forecast period
China, Japan, India, the United Kingdom, France, Italy, and a few other countries to remain lucrative for stakeholders

Get a Tailored Made Report to Match Your requirements, Ask from Market Research Expert@
https://www.futuremarketinsights.com/ask-question/rep-gb-1419

How is the Increase in Demand from Hospitals Industry Fuelling Sales of Medication Management System Suppliers?

Medication management systems are being deployed extensively by healthcare professionals in order to efficiently manage various information such as patient analysis, regulatory & compliance information, valuation analysis and other vital parameters in healthcare industry.

According to the report titled “Industries at a Glance: Hospitals” published by the Bureau of Labor Statistics, the United States hospitals industry is highly potential and progressive and comprises of medical, diagnostic, treatment, and other inpatient and outpatient services which include physician, nursing, and other health services. As stated in the report, the employment in this sector has decreased to 5,135.1 in thousands in February, 2021, compared to 5,136.3 in thousands in November, 2020. These data give a glimpse of the upcoming opportunities for medication management system providers around the globe.

Who is Winning in this Space?

With the competition getting stricter, key players in the global medication management system market are diversifying their products in order to target broader end-use sectors.

For instance,

Omnicell, Inc. lunched its new extensive range of products such as i.v.STATION Non-hazardous Compounding Robot, IVX Workflow, AccuFlex, MTS-350 Filler and Sealer, and others during the last 5 years
Cerner Corporation launched its new Automated Dispensing Cabinet, Drug Database Solutions, and others a couple of years back

More Valuable Insights In its latest report, FMI offers an unbiased analysis of the medication management system market, providing historical data for the period of 2016-2020 and forecast statistics for the period of 2021-2031. In order to understand the global market potential, its growth, and scope, the market is segmented on the basis of software type (computerized physician order entry, clinical decision support system solutions, electronic medication administration record, inventory management solutions, and other software types), end use (hospitals, pharmacies, and other healthcare institutions), and mode of delivery (on-premise solutions, web-based solutions, and cloud-based solutions), across seven major regions of the world (North America, Latin America, Europe, East Asia, South Asia, Oceania, and MEA).

Buy Now@ https://www.futuremarketinsights.com/checkout/1419

Medication Management System Segmentation by CategorySoftware Type

Computerized Physician Order Entry
Clinical Decision Support System Solutions
Electronic Medication Administration Record
Inventory Management Solutions
Other Software Types

End Use

Hospitals
Pharmacies
Other Healthcare Institutions

Mode of Delivery

On-Premise Solutions
Web-Based Solutions
Cloud-Based Solutions

About Future Market Insights (FMI)

Contact:

Demand for a Breast Pump Market: Notable Developments & Geographical Outlook 2022-2030

The Breast Pump Market Size are predicted to grow at a CAGR of 4.6% from 2022 to 2030, reaching a market worth of US$ 2.45 billion by the end of that year, up from US$ 1.72 billion in 2022.

Emerging economies are witnessing impressive growth in healthcare spending. This can be attributed to improvements in healthcare technology and changing lifestyle, which is fueling the demand for breast pumps among urban women.

Download Sample Copy @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5820

According to WHO, the global healthcare spending rose by 2.4% in 2014 over 2013. Healthcare spending is growing at a rate of 5% in developing regions. Rise in healthcare expenditure is expected to boost overall adoption of breast pumps among women, especially in Asia Pacific.

Breast pump adoption is as high as 85% among breast feeding women at 3 months post-birth. Furthermore, marketplace discussions indicate that the availability of breast pump accessory products will also encourage the adoption of electric breast pumps in developed markets. In this regard, infant product manufacturers are increasingly bundling other pump-related products, such as nursing bras and breast pumping bras, to sell complete package of breast pumps, which is anytime more profitable than isolated sales.

Electrical breast pump packages find more adoption than manual breast pump products due to better volume of output. These innovative solutions are projected to fuel breast pump market revenues in the global electric breast pumps market during the forecast period.

Report highlights the potential factors fueling the revenue growth of the breast pump market globally. A breast pump is a medical device used to elicit breast milk from lactating women. Breast pump products are available in two models, including manual breast pumps and electrical breast pumps. Electric breast pumps are available in two formats: single electric breast pumps and double electric breast pumps.

This report analyzes total revenue generated through sales of breast pump products, which include manual breast pumps and electric breast pump devices for breast feeding. Breast pump products are increasingly becoming a necessity among working women across the world as the inclusion of women in workforce is increasing globally. Since the last few years, the percentage of working women in workplaces across the globe has been declining (46.2% in 2019 as compared to 50.9% in 1990 as per “Catalyst”).

Ask the Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-5820

Breast Pumps Market Segmentation:

By Product Type

Open System Breast Pumps
Closed System Breast Pumps

By Technology Type

Electric Breast Pumps
- Single Electric Breast Pumps
- Double Electric Breast Pumps
Manual Breast Pumps

By End User

Homecare Settings
Healthcare Facilities

By Region

North America
Latin America
Western Europe
Eastern Europe
Japan
Asia Pacific Excluding Japan (APEJ)
Middle East & Africa (MEA)

Request Customization @ https://www.futuremarketinsights.com/ask-question/rep-gb-5820

Key Market Players:

Koninklijke Philips N.V.,
Pigeon Corporation,
Newell Brands,
Medela Inc.,
Ameda Inc.,
Hygeia II Medical Group Inc.,
Bailey Medical,
Mayborn Group Ltd. and Linco Baby Merchandise Works Co., Ltd.
Others

The Electric breast pump market is more technologically advanced with higher product pricing and low penetration. This category of breast pump comprises few global breast pump manufacturing companies. Potential new entrants in breast pump market are trying to capture and improve their market position by using innovative marketing strategies, such as inorganic growth. Breast pump manufacturers are expanding their product portfolio using latest technologies.

Availability of BPA free breast pump products is fuelling breast pump adoption in developed as well as more the affluent markets in developing regions. In the recent past, breast pump manufacturers have begun offering bisphenol A or BPA-free breast pump products to increase sales. BPA is a chemical used to make milk container or feeding bottle rigid and more resistant and has been associated with adverse health effects, such as neural and fertility issues. Examples of some BPA free breast pump products are Philips Avent Manual Comfort Breast Pump from Koninklijke Philips N.V. and BPA-free breast pumps by Medela, Inc.

Buy Now@ https://www.futuremarketinsights.com/checkout/5820

Rapid rise in promotional/supporting campaigns for Breast Pump products is fuelling revenue growth of the breast pump market. In November 2012, leading breast pump manufacturer Medela launched a campaign titled ‘Virtual Human Milk Collection Campaign’ to commemorate Prematurity Awareness Month, where the breast pump manufacturer encouraged and demonstrated the importance of breast milk for infants and babies. Medela has also donated US$ 30,000 worth of breastfeeding related products to various neonatal intensive care units across the U.S.

About Future Market Insights (FMI)

Contact:

Global Wound Irrigation Systems Market Booming Trends Supporting Growth and Forecast 2022-2032

The Global Wound Irrigation System Market is projected to reach a valuation of US$ 347.3 Mn by 2032, with sales growing at a sluggish CAGR of 2.6% from 2022 to 2032. Predicted to reach an estimated US$ 267.6 Mn in 2022, the wound irrigation system is primarily driven by acute wounds. This system is in high demand in emergency care and other urgent care services as many patients often seek out treatment for wounds and lacerations.

Request a Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-3775

Medical complications arising due to infections such as surgical site infection (SSI)- a wound infection with microbes, mainly bacteria, within 30 days of a surgical procedure- often carry a high risk of mortality and morbidity, specifically in oncological settings. SSI is one of the most common nosocomial infections and its management further burdens the healthcare system financially. One of the more reliable and effective prevention methods for SSI infection is wound irrigation.

The wound irrigation system is much preferable to swabbing or washing as it includes the flushing of the surgical incision with a solution that reduces the bacterial burden, and physically eradicates cell debris and trapped fluids.

Moreover, wound irrigation systems ensure the delivery of a regulated and stable pressure which is a primary requirement for effective wound care management. This feature coupled with much recent progress made in the design and production of new wound irrigation systems is presenting manufacturers with lucrative opportunities at the international level. The rising adoption of negative pressure wound therapy is spearheading the growth of wound irrigation systems.

The emergence of simultaneous wound irrigation technology has led to a surge in the demand for negative pressure wound therapy. These instruments supply a constant flow for the irrigant to the wound site directly from a wound irrigation delivery bag. The irrigant then exits the wound, carrying cellular debris from the wound into the negative pressure wound therapy device canister.

The use of these systems encourages the removal of bioburden and debris in the wound, eventually converting to positive procedural outcomes. Besides, other related benefits of wound irrigation systems are better patient compliance, quicker wound healing, and lower frequency of dressing changes, which in turn, promote cost savings and decrease workload within a hospital setting. All of these factors foster an environment of growth for the wound irrigation system market over the forecast period.

Request Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-3775

“Rising demand for new and innovative medical solutions for acute and chronic wound treatment will likely spur the growth of the wound irrigation system market over the forecast period,” says an FMI analyst.

Key Takeaways:

Heightened usage of wound irrigation saline for wound treatment is boosting the market prospects.
Preference for traditional wound care by healthcare practitioners may hamper the market growth.
The U.S. market is predicted to grow at 1.7% CAGR over the assessment period.
Independent clinical practices to drive the market growth in Germany.
Battery-operated wound irrigation kits to gain popularity over the forecast period.
Increasing occurrence of acute wounds to drive the overall market growth.

Competitive Landscape

Zimmer Biomet, Stryker Corporation, Centurion Medical Products, BSN Medical, Cooper Surgical Inc., C. R. Bard, Inc., Medtronic Plc., Bionix, Westmed, Inc., Becton, Dickinson, and Company among others are some of the major players in the wound irrigation system market profiled in the full version of the report.

Leading market players are focusing on product development and releasing new products into the market to expand their consumer base and strengthen their market position.

Ask an Analyst @ https://www.futuremarketinsights.com/ask-question/rep-gb-3775

More Insights into Wound Irrigation System Market Report

In its latest report, FMI offers an unbiased analysis of the global wound irrigation system market, providing historical data from 2012 to 2021 and forecast statistics for 2022 to 2032. To understand the global market potential, growth, and scope, the market is segmented on the basis of product type (manual operated (syringe based, spray based, nozzle based), battery operated), wound (acute wounds (surgical wounds, traumatic wounds, burns), chronic wounds (venous ulcers, pressure ulcers, diabetic foot ulcers, others), end user (hospitals, ambulatory surgical centers, clinics, long-term care centers, home care centers), and region.

According to the latest FMI reports, based on region, the wound irrigation system market in the United States is projected to grow substantially over the forecast period. The country will record a 1.7% CAGR during 2022-2032. Rising awareness of appropriate wound care is promoting the adoption of wound irrigation system in this region.

Rapid growth of healthcare infrastructure coupled with increasing incidences of surgical site infections further augment the sales of the wound irrigation system in this market. Apart from the U.S., China and Germany are expected to display substantial market growth over the assessment period.

Based on segmentation, by product type, the battery-operated wound irrigation systems will likely dominate the market in the upcoming years. In terms of wound type, acute wounds are the highest contributing segment during this period.

Table of Content

Executive Summary

1.1. Global Market Outlook

1.2. Demand Side Trends

1.3. Supply Side Trends

1.4. Analysis and Recommendations

Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

2.3. Inclusions and Exclusions

Key Market Trends

3.1. Key Trends Impacting the Market

3.2. Product Innovation / Development Trends

TOC Continued…!

Get detailed TOC @ https://www.futuremarketinsights.com/toc/rep-gb-3775

About Future Market Insights (FMI)

Contact:

Clinical Alarm Management Market Insights on Trends and Growth Forecast by 2029

The Clinical Alarm Management Market is on a pace to expand by ~13% annually, through 2029.

Heavy investments in the development of healthcare facilities and infrastructure has been radically changing patient engagement and experience in recent years.

Request for a sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-1713

Increasing adoption of clinical decision support tools and real-time communication system, in view of rapid advances in healthcare technologies, are projected to boost the demand for clinical alarm management.

Key Takeaways from Clinical Alarm Management Market Study

Adoption of clinical decision support tools and clinical alarm reporting software continues to broaden in both developing and developed countries.

Clinical alarm reporting software helps in identifying nonactionable alarms that could be fully adjusted or removed, contributing to 80% reduction in ventilator alarms.

Clinical alarm management solutions – central monitoring system in particular has been garnering significant traction, as it provides actionable intelligence to respond to alarm conditions with appropriate patient care or device management.

FMI reports that demand for clinical alarm management in hospitals and ambulatory surgical centers is likely to increase at the CAGR of ~14% and ~11% respectively, during the forecast period.

As compared to developing regions, the sales of clinical alarm management solution is anticipated to be higher in countries of North America and Western Europe.

Get a Customized Scope to Match Your Need Ask an Expert @ https://www.futuremarketinsights.com/ask-question/rep-gb-1713

Key Players Eyeing Greater Opportunities in Asia Pacific

Leading players in the clinical alarm management market are constantly focusing on expanding their business across Asia Pacific.

Increasing investments in the digitalization of healthcare infrastructure, especially in developing countries such as China and India, is likely to help attract different clinical alarm management solution providers to continue their businesses in these countries.

Further, with a wealth of innovation on the horizon, clinical alarm management market players are set to release advanced solutions and services for the end users.

Zebra Technologies offers alarm management solutions, which can deliver more than patient event notifications and secure text messaging.

Incorporation of new technologies such as Internet of Things (IoT) in the healthcare sector along with rising adoption of big data analytics has been leading to paradigm shift in patient care delivery.

Rapid inclination towards value-based healthcare is likely to remain instrumental to the growth of the clinical alarm management market in the years ahead.

Find More Valuable Insights on Clinical Alarm Management Market

In its new offering, Future Market Insights puts forward an unbiased analysis of the global clinical alarm management market, providing historical demand data (2014-2018) and forecast statistics for the period, 2019-2029.

The study provides key insights on the clinical alarm management market on the basis of component (solution and services) and end user (hospitals, clinics, ambulatory surgical centers, long-term and palliative care centers, home care, and other end users) across seven major regions.

Buy Now@ https://www.futuremarketinsights.com/checkout/1713

Clinical Alarm Management Market: Segmentation

Component

Solution

Clinical Decision Support Tool

Central Monitoring System

Mobility Solution

Clinical Alarm Reporting Software

Alarm Auditing Software

Service

Consulting

Implementation and Integration

Monitoring and Analytics

End User

Hospitals

Clinics

Ambulatory Surgical Centres

Long-term and Palliative Care Centres

Home Care

Others

Region

North America

Latin America

Western Europe

Eastern Europe

Asia Pacific

Excluding Japan

Japan

Middle East & Africa

About Future Market Insights (FMI)

Contact:

Global Flow Cytometry Market Report 2022: Consistent Levels of R&D Driving Sector Growth

Flow cytometry is used to monitor microscopic particles with the help of electronic devices called flow cytometers. Flow cytometry is used in stem cell research, in the development of immunology products and vaccines and also in CD4 testing. The Global Flow Cytometry Market is influenced by various factors such as medical and technological developments in flow cytometry products, rising use of flow cytometry in clinical trials, in detection of blood cancer, in research, in launching of new reagents for critical applications such as drug discovery and diagnostics and also in development of intuitive and user-friendly software are fuelling the growth of the flow cytometry market in the forthcoming timeline. Moreover, rising prevalence of AIDS and cancer has triggered the adoption of flow cytometry technology in scientific research. This is supporting the growth of the global flow cytometry market.

Request a report sample to gain comprehensive insights @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5263

The analytical and extensive research report on “Flow Cytometry Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2022)” published by Future Market Insights uncovers various factors of the global market for flow cytometry which can be used to analyse and grasp opportunities in the market across regions worldwide in order to carry out expansion programs in the future. According to the market analysis in this research report, the global flow cytometry market is projected to grow at a VAGR of 7.1% during the period of assessment 2017-2022.

Global Flow Cytometry Market Historical Analysis (2015 to 2021) Vs. Forecast Outlook (2022 to 2032)

The market value for flow cytometry was approximately 30.8% of the overall US$ 17.1 Billion of the global cell analysis market in 2021.

The sales of flow cytometry products expanded at a CAGR of 6.3% from 2017 to 2021, owing to the growing applications of flow cytometry in research and clinical practice.

The outbreak of Covid-19 was a turning point for the flow cytometry market trends. Analysis of the PBMC phenotype by flow cytometry helped to predict the likelihood that Covid-19 can progress clinically and showed that recovery from the infection is accompanied by improved antigen presentation and more potent adaptive immune responses. Therefore, during the pandemic, there was a rise in the need for portable flow cytometers, and this demand is anticipated to continue as the same type of viruses are anticipated to emerge in the future.

Ask an Analyst@ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-5263

5 Key Highlights on the Global Flow Cytometry Market

The global flow cytometry market is segmented by application, end user, technology, product type and region.

By application, the research segment is expected to dominate the global market with respect to high market share. By the end of 2022, this segment is estimated to reach a high market valuation of around US$ 1.8 Bn growing at a high CAGR during this period. The industrial segment is projected to grow at the highest rate during the assessment period and poised to gain a high BPS by the end of 2022.

By technology, the cell based segment is the largest segment. It is projected to grow at a CAGR of 7.2% throughout the period of forecast and is estimated to gain a very high valuation during the period of assessment.

North America region is a highly lucrative region for the growth of the global flow cytometry market. The market in North America is soaring at a higher pace and expected to surpass other regions.

By end user, the commercial organizations segment is expected to gain the highest BPS by end of 2022. Moreover, this segment demands increasing use of flow cytometry and is the largest and the fastest growing segment in the flow cytometry market.

In the product type category, the reagents and consumables have gained high traction in the recent years. This segment is a high contributor of growth of the global flow cytometry market. The reagents and consumables segment is estimated to gain a high BPS and grow at a high CAGR of 7.9% throughout the period of assessment.

We Offer tailor-made Solutions to fit Your Requirements, Request Customization @https://www.futuremarketinsights.com/customization-available/rep-gb-5263

Global Flow Cytometry Market: Competitive Landscape

The global flow cytometry market research study includes a separate section on competitive landscape in which it focuses on the key players and their in-depth analysis including company overview, SWOT analysis, developments, innovations, key financials and product portfolios. This extensive research report covers key companies such as Miltenyi Biotec GmbH, General Electric Company, Luminex Corporation, Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Merck & Co Inc., Agilent Technologies, Inc., Sysmex Corporation, Becton Dickinson and Company and Danaher Corporation.

About Future Market Insights (FMI)

Contact: